Syndax Pharmaceuticals (SNDX) Amortization of Deferred Charges (2024 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly Amortization of Deferred Charges came in at $56000.0 in Q1 2026, down 50.0% year-on-year from $112000.0 in Q1 2025, and up 5700.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Syndax Pharmaceuticals (SNDX) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $56000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 50.0% year-over-year to $56000.0 in Q1 2026; TTM through Mar 2026 was $172000.0, a 21.13% increase from a year earlier, with the FY2025 full-year figure at $228000.0, up 660.0% from the prior year.
- Amortization of Deferred Charges advanced to $56000.0 in Q1 2026 per SNDX's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $112000.0 in Q1 2025 and bottomed at -$1000.0 in Q4 2025.
- The 3-year median for Amortization of Deferred Charges is $55500.0 (2025), against an average of $52333.3.
- Across the five-year window, Amortization of Deferred Charges plunged 103.33% in 2025 and sank 50.0% in 2026, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $30000.0 in 2024, then tumbled by 103.33% to -$1000.0 in 2025, then jumped by 5700.0% to $56000.0 in 2026.
- Per Business Quant, the three latest SNDX Amortization of Deferred Charges figures stand at $56000.0 (Q1 2026), -$1000.0 (Q4 2025), and $62000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |